EWA
BIO icon

EP Wealth Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

EP Wealth Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,189
Closed -$589K – 368
2022
Q2 		$589K Buy
1,189
+802
+207% +$418K 0.01% 340
2022
Q1 		$218K Buy
+387
New +$233K ﹤0.01% 553

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EP Wealth Advisors's BIO Position: Q3 2022 in Review

EP Wealth Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 1,189 shares — an estimated $589K sold.

EP Wealth Advisors first reported a position in BIO in Q1 2022 and held it in 2 quarters. The position peaked at $589K in Q2 2022. 484 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

  • EP Wealth Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
  • EP Wealth Advisors sold 1,189 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $589K.
  • EP Wealth Advisors first reported a position in Bio-Rad Laboratories Class A in Q1 2022 and held it in 2 quarters.
  • EP Wealth Advisors's Bio-Rad Laboratories Class A position peaked at $589K in Q2 2022.
  • 484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on EP Wealth Advisors's 13F filing for Q3 2022, filed 2 Dec 2022.